ASKA Pharmaceutical Holdings Co (TSE:4886) Interest Expense : 円-40 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ASKA Pharmaceutical Holdings Co's interest expense for the three months ended in Dec. 2023 was 円 -10 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was 円-40 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ASKA Pharmaceutical Holdings Co's Operating Income for the three months ended in Dec. 2023 was 円 2,471 Mil. ASKA Pharmaceutical Holdings Co's Interest Expense for the three months ended in Dec. 2023 was 円 -10 Mil. ASKA Pharmaceutical Holdings Co's Interest Coverage for the quarter that ended in Dec. 2023 was 247.10. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ASKA Pharmaceutical Holdings Co Interest Expense Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Interest Expense Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Interest Expense

-56.00

-50.00

-40.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial							-12.00	-11.00	-10.00	-10.00	-9.00

ASKA Pharmaceutical Holdings Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-40 Mil.

ASKA Pharmaceutical Holdings Co (TSE:4886) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ASKA Pharmaceutical Holdings Co's Interest Expense for the three months ended in Dec. 2023 was 円-10 Mil. Its Operating Income for the three months ended in Dec. 2023 was 円2,471 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was 円6,925 Mil.

ASKA Pharmaceutical Holdings Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	2471	/	-10
	=	247.10

The higher the ratio, the stronger the company's financial strength is.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines